Search hospitals > Missouri > Saint Louis
Cardinal Glennon Children's Medical Center
Claim this profileSaint Louis, Missouri 63104
Global Leader in Tumors
Global Leader in Brain Tumor
Conducts research for Leukemia
Conducts research for Neuroblastoma
Conducts research for Lymphoma
221 reported clinical trials
5 medical researchers
Summary
Cardinal Glennon Children's Medical Center is a medical facility located in Saint Louis, Missouri. This center is recognized for care of Tumors, Brain Tumor, Leukemia, Neuroblastoma, Lymphoma and other specialties. Cardinal Glennon Children's Medical Center is involved with conducting 221 clinical trials across 362 conditions. There are 5 research doctors associated with this hospital, such as William Ferguson, MD, Nitin Chouthai, MD, Deepika Bhatla, MD, and Erik Masden, MD.Area of expertise
1Tumors
Global LeaderStage IV
Stage I
Stage II
2Brain Tumor
Global LeaderStage IV
Stage I
Stage II
Top PIs
William Ferguson, MDCardinal Glennon Children's Medical Center7 years of reported clinical research
Expert in Brain Tumor
Expert in Tumors
52 reported clinical trials
92 drugs studied
Nitin Chouthai, MDSt. Louis University1 year of reported clinical research
Studies Premature Birth
Studies Bleeding
3 reported clinical trials
7 drugs studied
Deepika Bhatla, MDSt. Louis University22 years of reported clinical research
Studies Bone Marrow Disease
Studies Blood Disorders
2 reported clinical trials
4 drugs studied
Erik Masden, MDCardinal Glennon Children's Hospital2 years of reported clinical research
Studies Congenital Heart Defects
Studies Atrioventricular Septal Defect
1 reported clinical trial
1 drug studied
Clinical Trials running at Cardinal Glennon Children's Medical Center
Brain Tumor
Osteosarcoma
Langerhans Cell Histiocytosis
Rhabdomyosarcoma
Neuroblastoma
Non-Hodgkin's Lymphoma
Astrocytoma
Germ Cell Tumors
Medulloblastoma
Rhabdoid Tumor
Selumetinib vs Carboplatin/Vincristine
for Brain Cancer
This phase III trial studies if selumetinib works just as well as the standard treatment with carboplatin/vincristine (CV) for subjects with NF1-associated low grade glioma (LGG), and to see if selumetinib is better than CV in improving vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low-grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether selumetinib works better in treating patients with NF1-associated low-grade glioma compared to standard therapy with carboplatin and vincristine.
Recruiting2 awards Phase 328 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Selumetinib + Vinblastine
for Low-Grade Glioma
This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common type of brain cancer) that has come back after prior treatment (recurrent) or does not respond to therapy (progressive). Selumetinib is a drug that works by blocking a protein that lets tumor cells grow without stopping. Vinblastine blocks cell growth by stopping cell division and may kill cancer cells. Giving selumetinib in combination with vinblastine may work better than selumetinib alone in treating recurrent or progressive low-grade glioma.
Recruiting2 awards Phase 339 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Cardinal Glennon Children's Medical Center?
Cardinal Glennon Children's Medical Center is a medical facility located in Saint Louis, Missouri. This center is recognized for care of Tumors, Brain Tumor, Leukemia, Neuroblastoma, Lymphoma and other specialties. Cardinal Glennon Children's Medical Center is involved with conducting 221 clinical trials across 362 conditions. There are 5 research doctors associated with this hospital, such as William Ferguson, MD, Nitin Chouthai, MD, Deepika Bhatla, MD, and Erik Masden, MD.